Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Lillicrap

Showing results (101-110 of 216) with videos related to

Pageof 22
Sort By:
Frontiers in Immunology|January 31, 2020
Tolerating Factor VIII: Recent ProgressSebastien Lacroix-Desmazes, Jan Voorberg, David Lillicrap, et al.
Frontiers in Immunology|March 3, 2020
Sedimentation Velocity Analytical Ultracentrifugation of Oxidized Recombinant Full-Length Factor VIIIPhilip M Zakas, John F Healey, Ian W Smith, et al.
Blood Transfusion = Trasfusione Del Sangue|August 3, 2016
Functional characterisation of the type 1 von Willebrand disease candidate VWF gene variants: p.M771I, p.L881R and p.P1413LErgul Berber, Mehmet Ozbil, Christine Brown, et al.
Research and Practice in Thrombosis and Haemostasis|September 1, 2020
Desmopressin responsiveness by age in type 1 von Willebrand diseaseNicola Goldberg, Rosane Nisenbaum, Hong Song, et al.
Journal of Hepatology|October 27, 2023
Adeno-associated viruses for gene therapy - clinical implications and liver-related complications, a guide for hepatologistsMarcus Maximilian Mücke, Sylvia Fong, Graham R Foster, et al.
Blood|September 3, 2016
Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia ASteven W Pipe, Robert R Montgomery, Kathleen P Pratt, et al.
Plos One|December 21, 2013
A novel cell-sheet technology that achieves durable factor VIII delivery in a mouse model of hemophilia AKohei Tatsumi, Mitsuhiko Sugimoto, David Lillicrap, et al.
Thrombosis and Haemostasis|May 15, 2002
Aberrant splicing and premature termination of transcription of the FVIII gene as a cause of severe canine hemophilia A: similarities with the intron 22 inversion mutation in human hemophiliaChristine Hough, Seiki Kamisue, Cherie Cameron, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 12, 2020
The diagnosis of a haemophilia A carrier over 2 decadesEvemie Dubé, Julie Gauthier, Clémence Merlen, et al.
Blood|April 8, 2010
Mutation-specific hemostatic variability in mice expressing common type 2B von Willebrand disease substitutionsMia Golder, Cynthia M Pruss, Carol Hegadorn, et al.
Pageof 22

Showing results (101-110 of 216) with videos related to

Sort By:
Pageof 22
Frontiers in Immunology|January 31, 2020
Tolerating Factor VIII: Recent ProgressSebastien Lacroix-Desmazes, Jan Voorberg, David Lillicrap, et al.
Frontiers in Immunology|March 3, 2020
Sedimentation Velocity Analytical Ultracentrifugation of Oxidized Recombinant Full-Length Factor VIIIPhilip M Zakas, John F Healey, Ian W Smith, et al.
Blood Transfusion = Trasfusione Del Sangue|August 3, 2016
Functional characterisation of the type 1 von Willebrand disease candidate VWF gene variants: p.M771I, p.L881R and p.P1413LErgul Berber, Mehmet Ozbil, Christine Brown, et al.
Research and Practice in Thrombosis and Haemostasis|September 1, 2020
Desmopressin responsiveness by age in type 1 von Willebrand diseaseNicola Goldberg, Rosane Nisenbaum, Hong Song, et al.
Journal of Hepatology|October 27, 2023
Adeno-associated viruses for gene therapy - clinical implications and liver-related complications, a guide for hepatologistsMarcus Maximilian Mücke, Sylvia Fong, Graham R Foster, et al.
Blood|September 3, 2016
Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia ASteven W Pipe, Robert R Montgomery, Kathleen P Pratt, et al.
Plos One|December 21, 2013
A novel cell-sheet technology that achieves durable factor VIII delivery in a mouse model of hemophilia AKohei Tatsumi, Mitsuhiko Sugimoto, David Lillicrap, et al.
Thrombosis and Haemostasis|May 15, 2002
Aberrant splicing and premature termination of transcription of the FVIII gene as a cause of severe canine hemophilia A: similarities with the intron 22 inversion mutation in human hemophiliaChristine Hough, Seiki Kamisue, Cherie Cameron, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 12, 2020
The diagnosis of a haemophilia A carrier over 2 decadesEvemie Dubé, Julie Gauthier, Clémence Merlen, et al.
Blood|April 8, 2010
Mutation-specific hemostatic variability in mice expressing common type 2B von Willebrand disease substitutionsMia Golder, Cynthia M Pruss, Carol Hegadorn, et al.
Pageof 22